|
MechanismTop II inhibitors |
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Hangzhou Taibo Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Hangzhou Taibo Pharmaceutical Co., Ltd.
100 Deals associated with Hangzhou Taibo Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Hangzhou Taibo Pharmaceutical Co., Ltd.